…
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -142.10M | -535.60M | -10.10M | 269.60M | 162.80M |
| Net income | -167.10M | -430.30M | -5.40M | 211.60M | 118.10M |
| Selling general administrative | 171.20M | 166.70M | 183.70M | 198.80M | 179.30M |
| Gross profit | 461.50M | 454.70M | 471.90M | 570.10M | 512.80M |
| Reconciled depreciation | 106.40M | 108.30M | 122.80M | 108.80M | 109.90M |
| Ebit | -69.00M | -437.80M | 83.20M | 342.70M | 227.30M |
| Ebitda | 37.40M | -329.50M | 206.00M | 451.50M | 337.20M |
| Depreciation and amortization | 106.40M | 108.30M | 122.80M | 108.80M | 109.90M |
| Non operating income net other | - | - | - | - | -75.90M |
| Operating income | 261.90M | 259.90M | 256.40M | 342.70M | 227.30M |
| Other operating expenses | 905.70M | 1146.50M | 1435.70M | 1327.30M | 1084.30M |
| Interest expense | 77.10M | 97.80M | 93.30M | 54.30M | 47.70M |
| Tax provision | 8.20M | -105.30M | -4.70M | 58.00M | 44.70M |
| Interest income | 4.40M | 6.90M | 6.30M | 7.50M | 4.40M |
| Net interest income | -73.90M | -90.90M | -87.00M | -54.30M | -47.70M |
| Non recurring | - | - | - | - | 0.60M |
| Income tax expense | 8.20M | -105.30M | -4.70M | 58.00M | 44.70M |
| Total revenue | 1167.60M | 1406.40M | 1692.10M | 1668.30M | 1391.50M |
| Total operating expenses | 199.60M | 194.80M | 215.50M | 229.10M | 205.60M |
| Cost of revenue | 706.10M | 951.70M | 1220.20M | 1098.20M | 878.70M |
| Total other income expense net | -404.00M | -795.50M | -266.50M | -73.10M | -64.50M |
| Net income from continuing ops | -150.30M | -430.30M | -5.40M | 211.60M | 118.10M |
| Net income applicable to common shares | - | - | - | 211.60M | 118.10M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1651.10M | 2022.60M | 2623.30M | 2736.50M | 2469.00M |
| Intangible assets | 215.50M | 323.90M | 385.30M | 404.80M | 337.60M |
| Other current assets | 32.30M | 66.60M | 42.90M | 42.50M | 6.50M |
| Total liab | 1621.40M | 1827.40M | 1991.90M | 2038.20M | 1795.20M |
| Total stockholder equity | 29.70M | 195.20M | 631.40M | 698.30M | 673.80M |
| Deferred long term liab | - | - | - | 5.10M | 114.60M |
| Other current liab | 190.40M | 85.80M | 84.70M | 104.50M | 91.40M |
| Common stock | 0.40M | 0.40M | 0.40M | 0.40M | 0.40M |
| Capital stock | 0.40M | 0.40M | 0.40M | 0.40M | 0.40M |
| Retained earnings | 404.90M | 572.00M | 1002.30M | 1007.70M | 796.10M |
| Other liab | - | - | - | 221.40M | 276.30M |
| Good will | 4.30M | 175.20M | 527.50M | 518.50M | 442.00M |
| Other assets | 388.20M | 0.60M | 232.90M | 268.30M | 291.40M |
| Cash | 78.10M | 68.00M | 95.90M | 76.70M | 275.40M |
| Total current liabilities | 341.30M | 264.10M | 362.90M | 303.50M | 268.90M |
| Current deferred revenue | - | 10.50M | 67.50M | 6.80M | 14.70M |
| Net debt | 1164.60M | 1386.70M | 1438.60M | 1413.20M | 974.60M |
| Short term debt | 58.90M | 78.20M | 103.10M | 17.40M | 37.00M |
| Short long term debt | 47.10M | 61.30M | 84.40M | 0.90M | 19.60M |
| Short long term debt total | 1242.70M | 1454.70M | 1534.50M | 1489.90M | 1250.00M |
| Other stockholder equity | -376.10M | -335.80M | -344.60M | -263.00M | -135.80M |
| Property plant equipment | - | - | - | 855.30M | 719.70M |
| Total current assets | 454.20M | 493.20M | 658.60M | 679.00M | 724.90M |
| Long term investments | 83.10M | 87.30M | 99.20M | 109.80M | 35.30M |
| Net tangible assets | - | - | - | -280.00M | -105.80M |
| Net receivables | 157.80M | 162.70M | 211.00M | 224.80M | 161.70M |
| Long term debt | 1161.40M | 1339.70M | 1382.80M | 1472.50M | 1250.00M |
| Inventory | 186.00M | 195.90M | 308.80M | 335.00M | 241.20M |
| Accounts payable | 92.00M | 94.50M | 158.40M | 174.80M | 125.80M |
| Accumulated other comprehensive income | 0.50M | -41.40M | -26.70M | -46.80M | 13.10M |
| Common stock total equity | - | - | - | - | 0.40M |
| Retained earnings total equity | - | - | - | - | 796.10M |
| Non currrent assets other | 139.40M | 137.50M | 111.80M | 220.10M | 202.70M |
| Non current assets total | 1196.90M | 1529.40M | 1964.70M | 2057.50M | 1744.10M |
| Capital lease obligations | 34.20M | 53.70M | 67.30M | 57.30M | 53.60M |
| Long term debt total | - | - | - | - | 1250.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -3.40M | -79.50M | -465.50M | -553.90M | -35.30M |
| Change to liabilities | - | - | - | 42.70M | 36.50M |
| Total cashflows from investing activities | -57.50M | -79.50M | -77.30M | -553.90M | -140.60M |
| Net borrowings | -193.60M | -67.10M | -7.30M | 199.00M | -26.00M |
| Total cash from financing activities | -252.20M | -70.20M | -99.90M | 48.10M | -133.10M |
| Change to operating activities | - | - | - | -8.60M | 21.60M |
| Net income | -167.10M | -430.30M | -5.40M | 211.60M | 118.10M |
| Change in cash | 26.00M | -25.30M | 27.60M | -198.70M | 17.60M |
| Begin period cash flow | 86.60M | 111.90M | 84.30M | 276.00M | 258.40M |
| End period cash flow | 112.60M | 86.60M | 111.90M | 77.30M | 276.00M |
| Total cash from operating activities | 331.20M | 128.60M | 205.10M | 313.10M | 293.00M |
| Depreciation | 106.40M | 108.30M | 122.80M | 108.80M | 109.90M |
| Other cashflows from investing activities | 3.60M | -1.60M | 3.40M | 10.50M | -1.50M |
| Change to inventory | 40.20M | 86.20M | 25.80M | -63.70M | -55.80M |
| Change to account receivables | 12.20M | 38.20M | 42.70M | -42.10M | -13.80M |
| Sale purchase of stock | -56.30M | -3.10M | -92.10M | -145.20M | -109.40M |
| Other cashflows from financing activities | -3.70M | -3.10M | -5.90M | 1158.10M | 1.60M |
| Change to netincome | - | - | - | 59.50M | 43.40M |
| Capital expenditures | 57.70M | 77.60M | 109.80M | 142.50M | 103.80M |
| Change receivables | - | - | - | - | -13.80M |
| Cash flows other operating | - | - | - | - | 73.60M |
| Cash and cash equivalents changes | - | - | - | - | 19.30M |
| Change in working capital | 22.70M | -10.00M | -67.80M | -66.80M | 21.60M |
| Stock based compensation | 18.30M | 11.90M | 10.60M | 16.10M | 12.30M |
| Other non cash items | 355.60M | 570.10M | 189.60M | 48.40M | 35.70M |
| Free cash flow | 273.50M | 51.00M | 95.30M | 170.60M | 189.20M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NGVT Ingevity Corp |
-0.48 0.76% |
62.76 | 95.55 | 9.97 | 2.01 | 50.03 | 3.00 | 16.84 |
| LIN Linde plc Ordinary Shares |
-0.71 0.13% |
525.84 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.01 0.02% |
42.70 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.01 0.00% |
213.36 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
0.06 0.02% |
355.82 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
4920 O'Hear Avenue, North Charleston, SC, United States, 29405
843 740 2300
1400
| Name | Title | Year Born |
|---|---|---|
| Mr. John C. Fortson | Pres, CEO & Director | 1967 |
| Ms. Mary Dean Hall | Exec. VP & CFO | 1958 |
| Ms. Stacy Lancaster Cozad | Exec. VP, Gen. Counsel & Sec. | 1971 |
| Mr. Stuart Edward Woodcock Jr. | Exec. VP & Pres of Performance Materials | 1966 |
| Mr. Phillip John Platt | Chief Accounting Officer, Corp. Controller & VP of Financial Planning | 1981 |
| Mr. Daniel Gallagher | VP of Investor Relations | NA |
| John Nypaver | VP of Treasurer & Investor Relations | NA |
| Ms. Christine Stunyo | Sr. VP & Chief HR Officer | NA |
| Mr. Richard White | Sr. VP of Performance Chemicals and Pres of Industrial Specialties & Pavement Technologies | 1963 |
| Mr. Erik Ripple | Sr. VP and Chief Growth & Innovation Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.